Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
International Journal of Clinical and Experimental Pathology|November 18, 2009
Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-upLiuyan Jiang, Andrea D Abati, Wyndham Wilson, et al.Leukemia Research|February 26, 2008
PRAME expression in hairy cell leukemiaEvgeny Arons, Tara Suntum, Inger Margulies, et al.Leukemia & Lymphoma|January 31, 2008
Flow cytometric minimal residual disease monitoring in patients with multiple myeloma undergoing autologous stem cell transplantation: a retrospective studyHong Liu, Constance Yuan, Jeremy Heinerich, et al.Cytometry. Part B, Clinical Cytometry|January 13, 2024
Standardization of flow cytometric detection of antigen expressionLinhua Tian, Aaron R Nelson, Tyler Lowe, et al.Cytometry. Part B, Clinical Cytometry|January 27, 2015
Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reportingMaria Arroz, Neil Came, Pei Lin, et al.Bone Marrow Transplantation|May 6, 2018
Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myelomaNishant Tageja, Neha Korde, Dickran Kazandjian, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 15, 2018
Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic LeukemiaGeorg Aue, Clare Sun, Delong Liu, et al.Cytometry. Part B, Clinical Cytometry|December 20, 2018
Assessment of plasma cell myeloma minimal residual disease testing by flow cytometry in an international inter-laboratory study: Is it ready for primetime use?Stuart D Scott, Matthew Fletcher, Helen Whitehouse, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2018
Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma PatientsSwati Khanna, Suzanne Graef, Francis Mussai, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2015
Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination TherapyMartin Skarzynski, Carsten U Niemann, Yuh Shan Lee, et al.Pageof 3